These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29536948)

  • 1. Optogenetic dissection of ictogenesis: in search of a targeted anti-epileptic therapy.
    Lillis KP; Staley KJ
    J Neural Eng; 2018 Aug; 15(4):041001. PubMed ID: 29536948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetics for controlling seizure circuits for translational approaches.
    Ledri M; Andersson M; Wickham J; Kokaia M
    Neurobiol Dis; 2023 Aug; 184():106234. PubMed ID: 37479090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic and chemogenetic therapies for epilepsy.
    Walker MC; Kullmann DM
    Neuropharmacology; 2020 May; 168():107751. PubMed ID: 31494141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Dissection of Neural Circuits: A Decade of Progress.
    Luo L; Callaway EM; Svoboda K
    Neuron; 2018 Apr; 98(2):256-281. PubMed ID: 29673479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optogenetic Low-Frequency Stimulation of Specific Neuronal Populations Abates Ictogenesis.
    Shiri Z; Lévesque M; Etter G; Manseau F; Williams S; Avoli M
    J Neurosci; 2017 Mar; 37(11):2999-3008. PubMed ID: 28209738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic tools for modulating and probing the epileptic network.
    Zhao M; Alleva R; Ma H; Daniel AG; Schwartz TH
    Epilepsy Res; 2015 Oct; 116():15-26. PubMed ID: 26354163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy and optogenetics: can seizures be controlled by light?
    Tønnesen J; Kokaia M
    Clin Sci (Lond); 2017 Jul; 131(14):1605-1616. PubMed ID: 28667062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light Up the Brain: The Application of Optogenetics in Cell-Type Specific Dissection of Mouse Brain Circuits.
    Lee C; Lavoie A; Liu J; Chen SX; Liu BH
    Front Neural Circuits; 2020; 14():18. PubMed ID: 32390806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optogenetic approaches to treat epilepsy.
    Wykes RC; Kullmann DM; Pavlov I; Magloire V
    J Neurosci Methods; 2016 Feb; 260():215-20. PubMed ID: 26072246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the hammer and the scalpel: selective circuit control for the epilepsies.
    Krook-Magnuson E; Soltesz I
    Nat Neurosci; 2015 Mar; 18(3):331-8. PubMed ID: 25710834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WONOEP appraisal: optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis.
    Mantoan Ritter L; Golshani P; Takahashi K; Dufour S; Valiante T; Kokaia M
    Epilepsia; 2014 Nov; 55(11):1693-702. PubMed ID: 25303540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitation, but not inhibition, of the fastigial nucleus provides powerful control over temporal lobe seizures.
    Streng ML; Krook-Magnuson E
    J Physiol; 2020 Jan; 598(1):171-187. PubMed ID: 31682010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders.
    Yogeeswari P; Sriram D; Vaigundaragavendran J
    Curr Drug Metab; 2005 Apr; 6(2):127-39. PubMed ID: 15853764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy.
    Amtul Z; Aziz AA
    Mol Neurobiol; 2017 Dec; 54(10):8211-8224. PubMed ID: 27905012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypocretin (orexin) system: from a neural circuitry perspective.
    Li SB; de Lecea L
    Neuropharmacology; 2020 May; 167():107993. PubMed ID: 32135427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glia-neuron interactions underlie state transitions to generalized seizures.
    Diaz Verdugo C; Myren-Svelstad S; Aydin E; Van Hoeymissen E; Deneubourg C; Vanderhaeghe S; Vancraeynest J; Pelgrims R; Cosacak MI; Muto A; Kizil C; Kawakami K; Jurisch-Yaksi N; Yaksi E
    Nat Commun; 2019 Aug; 10(1):3830. PubMed ID: 31444362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optogenetic Tools for Subcellular Applications in Neuroscience.
    Rost BR; Schneider-Warme F; Schmitz D; Hegemann P
    Neuron; 2017 Nov; 96(3):572-603. PubMed ID: 29096074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Rhodopsin Optogenetic Tools: Application for Analyses of Synaptic Transmission and of Neuronal Network Activity in Behavior.
    Glock C; Nagpal J; Gottschalk A
    Methods Mol Biol; 2015; 1327():87-103. PubMed ID: 26423970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug Target.
    Mertz C; Krarup S; Jensen CD; Lindholm SEH; Kjær C; Pinborg LH; Bak LK
    Neurochem Res; 2020 Jun; 45(6):1247-1255. PubMed ID: 31414342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal treatment for refractory epilepsy: hope for the future?
    Nilsen KE; Cock HR
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):141-53. PubMed ID: 15003390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.